The effect of wet cupping on serum lipid concentrations of clinically healthy young men: A randomized controlled trial

Journal of Alternative and Complementary Medicine

Volumn 13, Issue 1, 2007, Pages 79-82

  Niasari, Majid ^a,b   Kosari, Farid ^b   Ahmadi, Ali ^b  

^a Iran Society of Hejamat Research   (Iran)

^b UNIVERSITY OF TEHRAN   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ALTERNATIVE MEDICINE; ANALYSIS OF VARIANCE; ARTICLE; ATHEROSCLEROSIS; BRACHIAL VEIN; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN EXPERIMENT; LIPID BLOOD LEVEL; MALE; NORMAL HUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TECHNIQUE; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL; VEIN; WET CUPPING;

ADULT; ANALYSIS OF VARIANCE; ARTERIOSCLEROSIS; BLOOD CIRCULATION; BLOODLETTING; CHOLESTEROL, HDL; CHOLESTEROL, LDL; HUMANS; MALE; REFERENCE VALUES; TRIGLYCERIDES;

EID: 33847259653     PISSN: 10755535     EISSN: None     Source Type: Journal    
DOI: 10.1089/acm.2006.4226     Document Type: Article

References (11)

1. Lesley B, Hughes AM, Sykes J, et al. The New Shorter Oxford English Dictionary. New York: Oxford University Press. 1993.
2. Turk JL, Allen E. Bleeding and cupping. Ann R Coll Surg England 1983;65:128-131.
3. Wright SM, Finical J. Beyond leeches: Therapeutic phlebotomty today. Am J Nurs 2000;100:55,56,58-61.
4. Kumar H. Repeated blood donation effective in treating hyperlipidemia. J Assoc Phys India 1994;42:468-469.
5. Meyers DG, Jensen KC, Menitove JE. A historical cohort study of the effect of lowering body iron through blood donation on incident cardiac events. Transfusion 2002;42:1135-1139.
6. Kajinami K, Mebuchi H. Therapeutic effects of LDL apheresis in the prevention of atherosclerosis. Curr Opin Lipidol 1999;10:401-406.
7. Baller D, Notohamiprodjo G, Gleichmann U, et al. Improvement in coronary flow reverse determined by positron emmision tomography after 6 months of cholesterol-lowering therapy in patients with early stages of coronary atherosclerosis. Circulation 1999;99:2871-2875.
8. Ginsberg HN, Goldberg IJ. Disorders of intermediary metabolism. In: Braunwald E, Fauci AS, Kasper DL, et al, eds. Harrison's Principles of Internal Medicine. New York: McGraw-Hill, 2001;22:2245-2257.
9. Sharrett AR, Heiss G, Chambless LE, et al. Metabolic and lifestyle determinants of postprandial lipemia differ from those of fasting triglycerides: The atherosclerosis risk in communities (ARIC) study. Circulation 2001;104:1108-1113.
10. Braun LT, Davidson MH. Cholesterol lowering drugs bring benefits to high-risk populations even when LDL is normal. J Cardiovasc Nurs 2003;18:44-49.
11. Dörner K, Dorn-Zachertz D. Cholesterol determinations from skin puncture and venous blood have similar imprecisions. Eur J Clin Chem 1991;29:411-413.